APO Research
Talk to an analyst

APO RESEARCH · REPORT

Swine Reproductive and Respiratory Syndrome Vaccine

Swine reproductive and respiratory syndrome is an acute and highly contagious viral infection characterized by reproductive disorder and respiratory symptoms in pig population.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Swine reproductive and respiratory syndrome is an acute and highly contagious viral infection characterized by reproductive disorder and respiratory symptoms in pig population.

Selected research

Market Analysis & Forecast

Global Swine Reproductive and Respiratory Syndrome Vaccine Market Analysis and Forecast 2026-2032

31 December 2025204 pages

Choose your research edition.

Industry ResearchSwine Reproductive and Respiratory Syndrome Vaccine Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Swine Reproductive and Respiratory Syndrome Vaccine Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Swine Reproductive and Respiratory Syndrome Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Swine Reproductive and Respiratory Syndrome Vaccine Market Outlook and Growth Opportunities 2026207 pages · $4,250 USDMarket Analysis & ForecastGlobal Swine Reproductive and Respiratory Syndrome Vaccine Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

Swine reproductive and respiratory syndrome is an acute and highly contagious viral infection characterized by reproductive disorder and respiratory symptoms in pig population.

Boehringer ingelheim is the company with the largest market share, about 25 percent.

This report presents an overview of global market for Swine Reproductive and Respiratory Syndrome Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

Read the full market overview

This report researches the key producers of Swine Reproductive and Respiratory Syndrome Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Swine Reproductive and Respiratory Syndrome Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Swine Reproductive and Respiratory Syndrome Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Swine Reproductive and Respiratory Syndrome Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Swine Reproductive and Respiratory Syndrome Vaccine sales, projected growth trends, production technology, application and end-user industry.

Swine Reproductive and Respiratory Syndrome Vaccine Segment by Company

ASCENT CORPORATION

Boehringer-Ingelheim

MSD Animal Health

SPAH

Ceva

Chengdu TECH-BANK Biological Products Co,.Ltd

ringpu

QILU ANIMAL HEALTH PRODUCTS CO.,LTD

DAHUANONG

CAVAC

Komipharm

Agrovet

Bioveta

JINYU BIO-TECNOLOGY CO.,LTD

Phibro Animal Health

ANHUI TIANKANG(GROUP)SHRES O., LTD

Zoetis

WINSUN BIO

PULIKE BIOLOGICAL ENGINERING,INC.

Swine Reproductive and Respiratory Syndrome Vaccine Segment by Type

Active Vaccine

Inactivated Vaccines

Swine Reproductive and Respiratory Syndrome Vaccine Segment by Application

Government Tender

Market Sales

Swine Reproductive and Respiratory Syndrome Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Swine Reproductive and Respiratory Syndrome Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Swine Reproductive and Respiratory Syndrome Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Swine Reproductive and Respiratory Syndrome Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Swine Reproductive and Respiratory Syndrome Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Swine Reproductive and Respiratory Syndrome Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Swine Reproductive and Respiratory Syndrome Vaccine sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Swine Reproductive and Respiratory Syndrome Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Active Vaccine Major Manufacturers Table 3. Inactivated Vaccines Major Manufacturers Table 4. Global Swine Reproductive and Respiratory Syndrome Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Government Tender Major Manufacturers Table 6. Market Sales Major Manufacturers Table 7. Swine Reproductive and Respiratory Syndrome Vaccine Industry Trends Table 8. Swine Reproductive and Respiratory Syndrome Vaccine Industry Drivers Table 9. Swine Reproductive and Respiratory Syndrome Vaccine Industry Opportunities and Challenges Table 10. Swine Reproductive and Respiratory Syndrome Vaccine Industry Restraints Table 11. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Region (2021-2026) Table 15. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Region (2027-2032) Table 16. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 17. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Region (2021-2026) & (K Units) Table 18. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Region (2027-2032) & (K Units) Table 19. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Region (2021-2026) Table 20. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Region (2027-2032) Table 21. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Manufacturers (2021-2026) Table 25. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Price (USD/Unit) of Manufacturers (2021-2026) Table 26. Global Swine Reproductive and Respiratory Syndrome Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Swine Reproductive and Respiratory Syndrome Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Swine Reproductive and Respiratory Syndrome Vaccine Manufacturers, Product Type & Application Table 29. Global Swine Reproductive and Respiratory Syndrome Vaccine Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Swine Reproductive and Respiratory Syndrome Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Type (2021-2026) Table 36. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Type (2027-2032) Table 37. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 38. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Type (2021-2026) & (K Units) Table 39. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Type (2027-2032) & (K Units) Table 40. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Type (2021-2026) Table 41. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Type (2027-2032) Table 42. Global Swine Reproductive and Respiratory Syndrome Vaccine Price by Type (2021-2026) & (USD/Unit) Table 43. Global Swine Reproductive and Respiratory Syndrome Vaccine Price by Type (2027-2032) & (USD/Unit) Table 44. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Application (2021-2026) Table 48. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Application (2027-2032) Table 49. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 50. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application (2021-2026) & (K Units) Table 51. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application (2027-2032) & (K Units) Table 52. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Application (2021-2026) Table 53. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Application (2027-2032) Table 54. Global Swine Reproductive and Respiratory Syndrome Vaccine Price by Application (2021-2026) & (USD/Unit) Table 55. Global Swine Reproductive and Respiratory Syndrome Vaccine Price by Application (2027-2032) & (USD/Unit) Table 56. ASCENT CORPORATION Company Information Table 57. ASCENT CORPORATION Business Overview Table 58. ASCENT CORPORATION Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 59. ASCENT CORPORATION Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio Table 60. ASCENT CORPORATION Recent Development Table 61. Boehringer-Ingelheim Company Information Table 62. Boehringer-Ingelheim Business Overview Table 63. Boehringer-Ingelheim Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 64. Boehringer-Ingelheim Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio Table 65. Boehringer-Ingelheim Recent Development Table 66. MSD Animal Health Company Information Table 67. MSD Animal Health Business Overview Table 68. MSD Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 69. MSD Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio Table 70. MSD Animal Health Recent Development Table 71. SPAH Company Information Table 72. SPAH Business Overview Table 73. SPAH Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 74. SPAH Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio Table 75. SPAH Recent Development Table 76. Ceva Company Information Table 77. Ceva Business Overview Table 78. Ceva Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 79. Ceva Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio Table 80. Ceva Recent Development Table 81. Chengdu TECH-BANK Biological Products Co,.Ltd Company Information Table 82. Chengdu TECH-BANK Biological Products Co,.Ltd Business Overview Table 83. Chengdu TECH-BANK Biological Products Co,.Ltd Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 84. Chengdu TECH-BANK Biological Products Co,.Ltd Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio Table 85. Chengdu TECH-BANK Biological Products Co,.Ltd Recent Development Table 86. ringpu Company Information Table 87. ringpu Business Overview Table 88. ringpu Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 89. ringpu Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio Table 90. ringpu Recent Development Table 91. QILU ANIMAL HEALTH PRODUCTS CO.,LTD Company Information Table 92. QILU ANIMAL HEALTH PRODUCTS CO.,LTD Business Overview Table 93. QILU ANIMAL HEALTH PRODUCTS CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 94. QILU ANIMAL HEALTH PRODUCTS CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio Table 95. QILU ANIMAL HEALTH PRODUCTS CO.,LTD Recent Development Table 96. DAHUANONG Company Information Table 97. DAHUANONG Business Overview Table 98. DAHUANONG Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 99. DAHUANONG Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio Table 100. DAHUANONG Recent Development Table 101. CAVAC Company Information Table 102. CAVAC Business Overview Table 103. CAVAC Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 104. CAVAC Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio Table 105. CAVAC Recent Development Table 106. Komipharm Company Information Table 107. Komipharm Business Overview Table 108. Komipharm Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 109. Komipharm Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio Table 110. Komipharm Recent Development Table 111. Agrovet Company Information Table 112. Agrovet Business Overview Table 113. Agrovet Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 114. Agrovet Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio Table 115. Agrovet Recent Development Table 116. Bioveta Company Information Table 117. Bioveta Business Overview Table 118. Bioveta Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 119. Bioveta Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio Table 120. Bioveta Recent Development Table 121. JINYU BIO-TECNOLOGY CO.,LTD Company Information Table 122. JINYU BIO-TECNOLOGY CO.,LTD Business Overview Table 123. JINYU BIO-TECNOLOGY CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 124. JINYU BIO-TECNOLOGY CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio Table 125. JINYU BIO-TECNOLOGY CO.,LTD Recent Development Table 126. Phibro Animal Health Company Information Table 127. Phibro Animal Health Business Overview Table 128. Phibro Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 129. Phibro Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio Table 130. Phibro Animal Health Recent Development Table 131. ANHUI TIANKANG(GROUP)SHRES O., LTD Company Information Table 132. ANHUI TIANKANG(GROUP)SHRES O., LTD Business Overview Table 133. ANHUI TIANKANG(GROUP)SHRES O., LTD Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 134. ANHUI TIANKANG(GROUP)SHRES O., LTD Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio Table 135. ANHUI TIANKANG(GROUP)SHRES O., LTD Recent Development Table 136. Zoetis Company Information Table 137. Zoetis Business Overview Table 138. Zoetis Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 139. Zoetis Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio Table 140. Zoetis Recent Development Table 141. WINSUN BIO Company Information Table 142. WINSUN BIO Business Overview Table 143. WINSUN BIO Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 144. WINSUN BIO Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio Table 145. WINSUN BIO Recent Development Table 146. PULIKE BIOLOGICAL ENGINERING,INC. Company Information Table 147. PULIKE BIOLOGICAL ENGINERING,INC. Business Overview Table 148. PULIKE BIOLOGICAL ENGINERING,INC. Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 149. PULIKE BIOLOGICAL ENGINERING,INC. Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio Table 150. PULIKE BIOLOGICAL ENGINERING,INC. Recent Development Table 151. North America Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 152. North America Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 153. North America Swine Reproductive and Respiratory Syndrome Vaccine Sales by Type (2021-2026) & (K Units) Table 154. North America Swine Reproductive and Respiratory Syndrome Vaccine Sales by Type (2027-2032) & (K Units) Table 155. North America Swine Reproductive and Respiratory Syndrome Vaccine Sales Price by Type (2021-2026) & (USD/Unit) Table 156. North America Swine Reproductive and Respiratory Syndrome Vaccine Sales Price by Type (2027-2032) & (USD/Unit) Table 157. North America Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 158. North America Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 159. North America Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application (2021-2026) & (K Units) Table 160. North America Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application (2027-2032) & (K Units) Table 161. North America Swine Reproductive and Respiratory Syndrome Vaccine Sales Price by Application (2021-2026) & (USD/Unit) Table 162. North America Swine Reproductive and Respiratory Syndrome Vaccine Sales Price by Application (2027-2032) & (USD/Unit) Table 163. North America Swine Reproductive and Respiratory Syndrome Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 164. North America Swine Reproductive and Respiratory Syndrome Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 165. North America Swine Reproductive and Respiratory Syndrome Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 166. North America Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 167. North America Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2021-2026) & (K Units) Table 168. North America Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2027-2032) & (K Units) Table 169. North America Swine Reproductive and Respiratory Syndrome Vaccine Sales Price by Country (2021-2026) & (USD/Unit) Table 170. North America Swine Reproductive and Respiratory Syndrome Vaccine Sales Price by Country (2027-2032) & (USD/Unit) Table 171. United States Swine Reproductive and Respiratory Syndrome Vaccine Revenue (2021-2032) & (US$ Million) Table 172. Canada Swine Reproductive and Respiratory Syndrome Vaccine Revenue (2021-2032) & (US$ Million) Table 173. Mexico Swine Reproductive and Respiratory Syndrome Vaccine Revenue (2021-2032) & (US$ Million) Table 174. Europe Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 175. Europe Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 176. Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales by Type (2021-2026) & (K Units) Table 177. Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales by Type (2027-2032) & (K Units) Table 178. Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales Price by Type (2021-2026) & (USD/Unit) Table 179. Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales Price by Type (2027-2032) & (USD/Unit) Table 180. Europe Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 181. Europe Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 182. Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application (2021-2026) & (K Units) Table 183. Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application (2027-2032) & (K Units) Table 184. Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales Price by Application (2021-2026) & (USD/Unit) Table 185. Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales Price by Application (2027-2032) & (USD/Unit) Table 186. Europe Swine Reproductive and Respiratory Syndrome Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 187. Europe Swine Reproductive and Respiratory Syndrome Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 188. Europe Swine Reproductive and Respiratory Syndrome Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 189. Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 190. Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2021-2026) & (K Units) Table 191. Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2027-2032) & (K Units) Table 192. Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales Price by Country (2021-2026) & (USD/Unit) Table 193. Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales Price by Country (2027-2032) & (USD/Unit) Table 194. Germany Swine Reproductive and Respiratory Syndrome Vaccine Revenue (2021-2032) & (US$ Million) Table 195. France Swine Reproductive and Respiratory Syndrome Vaccine Revenue (2021-2032) & (US$ Million) Table 196. U.K. Swine Reproductive and Respiratory Syndrome Vaccine Revenue (2021-2032) & (US$ Million) Table 197. Italy Swine Reproductive and Respiratory Syndrome Vaccine Revenue (2021-2032) & (US$ Million) Table 198. Russia Swine Reproductive and Respiratory Syndrome Vaccine Revenue (2021-2032) & (US$ Million) Table 199. Spain Swine Reproductive and Respiratory Syndrome Vaccine Revenue (2021-2032) & (US$ Million) Table 200. Netherlands Swine Reproductive and Respiratory Syndrome Vaccine Revenue (2021-2032) & (US$ Million) Table 201. Switzerland Swine Reproductive and Respiratory Syndrome Vaccine Revenue (2021-2032) & (US$ Million) Table 202. Sweden Swine Reproductive and Respiratory Syndrome Vaccine Revenue (2021-2032) & (US$ Million) Table 203. Poland Swine Reproductive and Respiratory Syndrome Vaccine Revenue (2021-2032) & (US$ Million) Table 204. China Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 205. China Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 206. China Swine Reproductive and Respiratory Syndrome Vaccine Sales by Type (2021-2026) & (K Units) Table 207. China Swine Reproductive and Respiratory Syndrome Vaccine Sales by Type (2027-2032) & (K Units) Table 208. China Swine Reproductive and Respiratory Syndrome Vaccine Sales Price by Type (2021-2026) & (USD/Unit) Table 209. China Swine Reproductive and Respiratory Syndrome Vaccine Sales Price by Type (2027-2032) & (USD/Unit) Table 210. China Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 211. China Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 212. China Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application (2021-2026) & (K Units) Table 213. China Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application (2027-2032) & (K Units) Table 214. China Swine Reproductive and Respiratory Syndrome Vaccine Sales Price by Application (2021-2026) & (USD/Unit) Table 215. China Swine Reproductive and Respiratory Syndrome Vaccine Sales Price by Application (2027-2032) & (USD/Unit) Table 216. Asia Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 217. Asia Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 218. Asia Swine Reproductive and Respiratory Syndrome Vaccine Sales by Type (2021-2026) & (K Units) Table 219. Asia Swine Reproductive and Respiratory Syndrome Vaccine Sales by Type (2027-2032) & (K Units) Table 220. Asia Swine Reproductive and Respiratory Syndrome Vaccine Sales Price by Type (2021-2026) & (USD/Unit) Table 221. Asia Swine Reproductive and Respiratory Syndrome Vaccine Sales Price by Type (2027-2032) & (USD/Unit) Table 222. Asia Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 223. Asia Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 224. Asia Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application (2021-2026) & (K Units) Table 225. Asia Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application (2027-2032) & (K Units) Table 226. Asia Swine Reproductive and Respiratory Syndrome Vaccine Sales Price by Application (2021-2026) & (USD/Unit) Table 227. Asia Swine Reproductive and Respiratory Syndrome Vaccine Sales Price by Application (2027-2032) & (USD/Unit) Table 228. Asia Swine Reproductive and Respiratory Syndrome Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 229. Asia Swine Reproductive and Respiratory Syndrome Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 230. Asia Swine Reproductive and Respiratory Syndrome Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 231. Asia Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 232. Asia Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2021-2026) & (K Units) Table 233. Asia Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2027-2032) & (K Units) Table 234. Asia Swine Reproductive and Respiratory Syndrome Vaccine Sales Price by Country (2021-2026) & (USD/Unit) Table 235. Asia Swine Reproductive and Respiratory Syndrome Vaccine Sales Price by Country (2027-2032) & (USD/Unit) Table 236. Japan Swine Reproductive and Respiratory Syndrome Vaccine Revenue (2021-2032) & (US$ Million) Table 237. South Korea Swine Reproductive and Respiratory Syndrome Vaccine Revenue (2021-2032) & (US$ Million) Table 238. India Swine Reproductive and Respiratory Syndrome Vaccine Revenue (2021-2032) & (US$ Million) Table 239. Australia Swine Reproductive and Respiratory Syndrome Vaccine Revenue (2021-2032) & (US$ Million) Table 240. Taiwan Swine Reproductive and Respiratory Syndrome Vaccine Revenue (2021-2032) & (US$ Million) Table 241. Southeast Asia Swine Reproductive and Respiratory Syndrome Vaccine Revenue (2021-2032) & (US$ Million) Table 242. SAMEA Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 243. SAMEA Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 244. SAMEA Swine Reproductive and Respiratory Syndrome Vaccine Sales by Type (2021-2026) & (K Units) Table 245. SAMEA Swine Reproductive and Respiratory Syndrome Vaccine Sales by Type (2027-2032) & (K Units) Table 246. SAMEA Swine Reproductive and Respiratory Syndrome Vaccine Sales Price by Type (2021-2026) & (USD/Unit) Table 247. SAMEA Swine Reproductive and Respiratory Syndrome Vaccine Sales Price by Type (2027-2032) & (USD/Unit) Table 248. SAMEA Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 249. SAMEA Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 250. SAMEA Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application (2021-2026) & (K Units) Table 251. SAMEA Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application (2027-2032) & (K Units) Table 252. SAMEA Swine Reproductive and Respiratory Syndrome Vaccine Sales Price by Application (2021-2026) & (USD/Unit) Table 253. SAMEA Swine Reproductive and Respiratory Syndrome Vaccine Sales Price by Application (2027-2032) & (USD/Unit) Table 254. SAMEA Swine Reproductive and Respiratory Syndrome Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 255. SAMEA Swine Reproductive and Respiratory Syndrome Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 256. SAMEA Swine Reproductive and Respiratory Syndrome Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 257. SAMEA Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 258. SAMEA Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2021-2026) & (K Units) Table 259. SAMEA Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2027-2032) & (K Units) Table 260. SAMEA Swine Reproductive and Respiratory Syndrome Vaccine Sales Price by Country (2021-2026) & (USD/Unit) Table 261. SAMEA Swine Reproductive and Respiratory Syndrome Vaccine Sales Price by Country (2027-2032) & (USD/Unit) Table 262. Brazil Swine Reproductive and Respiratory Syndrome Vaccine Revenue (2021-2032) & (US$ Million) Table 263. Argentina Swine Reproductive and Respiratory Syndrome Vaccine Revenue (2021-2032) & (US$ Million) Table 264. Chile Swine Reproductive and Respiratory Syndrome Vaccine Revenue (2021-2032) & (US$ Million) Table 265. Colombia Swine Reproductive and Respiratory Syndrome Vaccine Revenue (2021-2032) & (US$ Million) Table 266. Peru Swine Reproductive and Respiratory Syndrome Vaccine Revenue (2021-2032) & (US$ Million) Table 267. Saudi Arabia Swine Reproductive and Respiratory Syndrome Vaccine Revenue (2021-2032) & (US$ Million) Table 268. Israel Swine Reproductive and Respiratory Syndrome Vaccine Revenue (2021-2032) & (US$ Million) Table 269. UAE Swine Reproductive and Respiratory Syndrome Vaccine Revenue (2021-2032) & (US$ Million) Table 270. Turkey Swine Reproductive and Respiratory Syndrome Vaccine Revenue (2021-2032) & (US$ Million) Table 271. Iran Swine Reproductive and Respiratory Syndrome Vaccine Revenue (2021-2032) & (US$ Million) Table 272. Egypt Swine Reproductive and Respiratory Syndrome Vaccine Revenue (2021-2032) & (US$ Million) Table 273. Key Raw Materials Table 274. Raw Materials Key Suppliers Table 275. Swine Reproductive and Respiratory Syndrome Vaccine Distributors List Table 276. Swine Reproductive and Respiratory Syndrome Vaccine Customers List Table 277. Research Programs/Design for This Report Table 278. Authors List of This Report Table 279. Secondary Sources Table 280. Primary Sources List of Figures Figure 1. Swine Reproductive and Respiratory Syndrome Vaccine Image Figure 2. Global Swine Reproductive and Respiratory Syndrome Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Swine Reproductive and Respiratory Syndrome Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 4. Active Vaccine Image Figure 5. Inactivated Vaccines Image Figure 6. Global Swine Reproductive and Respiratory Syndrome Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Swine Reproductive and Respiratory Syndrome Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 8. Government Tender Image Figure 9. Market Sales Image Figure 10. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue (2021-2032) & (US$ Million) Figure 12. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Region (2021-2032) Figure 15. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales (2021-2032) & (K Units) Figure 16. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 17. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Swine Reproductive and Respiratory Syndrome Vaccine Sales YoY (2021-2032) & (K Units) Figure 19. Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales YoY (2021-2032) & (K Units) Figure 20. China Swine Reproductive and Respiratory Syndrome Vaccine Sales YoY (2021-2032) & (K Units) Figure 21. Asia (Excluding China) Swine Reproductive and Respiratory Syndrome Vaccine Sales YoY (2021-2032) & (K Units) Figure 22. South America, Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales YoY (2021-2032) & (K Units) Figure 23. Global Swine Reproductive and Respiratory Syndrome Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Swine Reproductive and Respiratory Syndrome Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Type (2021-2032) Figure 29. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 30. Global Swine

Scope & coverage.

Types
  • Active Vaccine
  • Inactivated Vaccines
Applications
  • Government Tender
  • Market Sales
Companies covered
  • ASCENT CORPORATION
  • Boehringer-Ingelheim
  • MSD Animal Health
  • SPAH
  • Ceva
  • Chengdu TECH-BANK Biological Products Co,.Ltd
  • ringpu
  • QILU ANIMAL HEALTH PRODUCTS CO.,LTD
  • DAHUANONG
  • CAVAC
  • Komipharm
  • Agrovet
  • Bioveta
  • JINYU BIO-TECNOLOGY CO.,LTD
  • Phibro Animal Health
  • ANHUI TIANKANG(GROUP)SHRES O., LTD
  • Zoetis
  • WINSUN BIO
  • PULIKE BIOLOGICAL ENGINERING,INC.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Swine Reproductive and Respiratory Syndrome Vaccine Market by Type
  3. 1.2.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Active Vaccine
  5. 1.2.3 Inactivated Vaccines
  6. 1.3 Swine Reproductive and Respiratory Syndrome Vaccine Market by Application
  7. 1.3.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Government Tender
  9. 1.3.3 Market Sales
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Swine Reproductive and Respiratory Syndrome Vaccine Market Dynamics
  1. 2.1 Swine Reproductive and Respiratory Syndrome Vaccine Industry Trends
  2. 2.2 Swine Reproductive and Respiratory Syndrome Vaccine Industry Drivers
  3. 2.3 Swine Reproductive and Respiratory Syndrome Vaccine Industry Opportunities and Challenges
  4. 2.4 Swine Reproductive and Respiratory Syndrome Vaccine Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Region
  3. 3.2.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Region (2021-2026)
  5. 3.2.3 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Region (2027-2032)
  6. 3.2.4 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Region
  9. 3.4.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Region (2021-2026)
  11. 3.4.3 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Region (2027-2032)
  12. 3.4.4 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Manufacturers
  2. 4.1.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Swine Reproductive and Respiratory Syndrome Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Manufacturers
  6. 4.2.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Swine Reproductive and Respiratory Syndrome Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Swine Reproductive and Respiratory Syndrome Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Swine Reproductive and Respiratory Syndrome Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Swine Reproductive and Respiratory Syndrome Vaccine Manufacturers, Product Type & Application
  13. 4.7 Global Swine Reproductive and Respiratory Syndrome Vaccine Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Market CR5 and HHI
  16. 4.8.2 2025 Swine Reproductive and Respiratory Syndrome Vaccine Tier 1, Tier 2, and Tier 3
5 Swine Reproductive and Respiratory Syndrome Vaccine Market by Type
  1. 5.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Type
  2. 5.1.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Type
  6. 5.2.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Type (2021-2032)
  9. 5.3 Global Swine Reproductive and Respiratory Syndrome Vaccine Price by Type
6 Swine Reproductive and Respiratory Syndrome Vaccine Market by Application
  1. 6.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Application
  2. 6.1.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application
  6. 6.2.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Application (2021-2032)
  9. 6.3 Global Swine Reproductive and Respiratory Syndrome Vaccine Price by Application
7 Company Profiles
  1. 7.1 ASCENT CORPORATION
  2. 7.1.1 ASCENT CORPORATION Company Information
  3. 7.1.2 ASCENT CORPORATION Business Overview
  4. 7.1.3 ASCENT CORPORATION Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 ASCENT CORPORATION Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
  6. 7.1.5 ASCENT CORPORATION Recent Developments
  7. 7.2 Boehringer-Ingelheim
  8. 7.2.1 Boehringer-Ingelheim Company Information
  9. 7.2.2 Boehringer-Ingelheim Business Overview
  10. 7.2.3 Boehringer-Ingelheim Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Boehringer-Ingelheim Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
  12. 7.2.5 Boehringer-Ingelheim Recent Developments
  13. 7.3 MSD Animal Health
  14. 7.3.1 MSD Animal Health Company Information
  15. 7.3.2 MSD Animal Health Business Overview
  16. 7.3.3 MSD Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 MSD Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
  18. 7.3.5 MSD Animal Health Recent Developments
  19. 7.4 SPAH
  20. 7.4.1 SPAH Company Information
  21. 7.4.2 SPAH Business Overview
  22. 7.4.3 SPAH Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 SPAH Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
  24. 7.4.5 SPAH Recent Developments
  25. 7.5 Ceva
  26. 7.5.1 Ceva Company Information
  27. 7.5.2 Ceva Business Overview
  28. 7.5.3 Ceva Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Ceva Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
  30. 7.5.5 Ceva Recent Developments
  31. 7.6 Chengdu TECH-BANK Biological Products Co,.Ltd
  32. 7.6.1 Chengdu TECH-BANK Biological Products Co,.Ltd Company Information
  33. 7.6.2 Chengdu TECH-BANK Biological Products Co,.Ltd Business Overview
  34. 7.6.3 Chengdu TECH-BANK Biological Products Co,.Ltd Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Chengdu TECH-BANK Biological Products Co,.Ltd Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
  36. 7.6.5 Chengdu TECH-BANK Biological Products Co,.Ltd Recent Developments
  37. 7.7 ringpu
  38. 7.7.1 ringpu Company Information
  39. 7.7.2 ringpu Business Overview
  40. 7.7.3 ringpu Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 ringpu Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
  42. 7.7.5 ringpu Recent Developments
  43. 7.8 QILU ANIMAL HEALTH PRODUCTS CO.,LTD
  44. 7.8.1 QILU ANIMAL HEALTH PRODUCTS CO.,LTD Company Information
  45. 7.8.2 QILU ANIMAL HEALTH PRODUCTS CO.,LTD Business Overview
  46. 7.8.3 QILU ANIMAL HEALTH PRODUCTS CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 QILU ANIMAL HEALTH PRODUCTS CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
  48. 7.8.5 QILU ANIMAL HEALTH PRODUCTS CO.,LTD Recent Developments
  49. 7.9 DAHUANONG
  50. 7.9.1 DAHUANONG Company Information
  51. 7.9.2 DAHUANONG Business Overview
  52. 7.9.3 DAHUANONG Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 DAHUANONG Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
  54. 7.9.5 DAHUANONG Recent Developments
  55. 7.10 CAVAC
  56. 7.10.1 CAVAC Company Information
  57. 7.10.2 CAVAC Business Overview
  58. 7.10.3 CAVAC Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 CAVAC Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
  60. 7.10.5 CAVAC Recent Developments
  61. 7.11 Komipharm
  62. 7.11.1 Komipharm Company Information
  63. 7.11.2 Komipharm Business Overview
  64. 7.11.3 Komipharm Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Komipharm Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
  66. 7.11.5 Komipharm Recent Developments
  67. 7.12 Agrovet
  68. 7.12.1 Agrovet Company Information
  69. 7.12.2 Agrovet Business Overview
  70. 7.12.3 Agrovet Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Agrovet Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
  72. 7.12.5 Agrovet Recent Developments
  73. 7.13 Bioveta
  74. 7.13.1 Bioveta Company Information
  75. 7.13.2 Bioveta Business Overview
  76. 7.13.3 Bioveta Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Bioveta Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
  78. 7.13.5 Bioveta Recent Developments
  79. 7.14 JINYU BIO-TECNOLOGY CO.,LTD
  80. 7.14.1 JINYU BIO-TECNOLOGY CO.,LTD Company Information
  81. 7.14.2 JINYU BIO-TECNOLOGY CO.,LTD Business Overview
  82. 7.14.3 JINYU BIO-TECNOLOGY CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 JINYU BIO-TECNOLOGY CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
  84. 7.14.5 JINYU BIO-TECNOLOGY CO.,LTD Recent Developments
  85. 7.15 Phibro Animal Health
  86. 7.15.1 Phibro Animal Health Company Information
  87. 7.15.2 Phibro Animal Health Business Overview
  88. 7.15.3 Phibro Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Phibro Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
  90. 7.15.5 Phibro Animal Health Recent Developments
  91. 7.16 ANHUI TIANKANG(GROUP)SHRES O., LTD
  92. 7.16.1 ANHUI TIANKANG(GROUP)SHRES O., LTD Company Information
  93. 7.16.2 ANHUI TIANKANG(GROUP)SHRES O., LTD Business Overview
  94. 7.16.3 ANHUI TIANKANG(GROUP)SHRES O., LTD Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 ANHUI TIANKANG(GROUP)SHRES O., LTD Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
  96. 7.16.5 ANHUI TIANKANG(GROUP)SHRES O., LTD Recent Developments
  97. 7.17 Zoetis
  98. 7.17.1 Zoetis Company Information
  99. 7.17.2 Zoetis Business Overview
  100. 7.17.3 Zoetis Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Zoetis Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
  102. 7.17.5 Zoetis Recent Developments
  103. 7.18 WINSUN BIO
  104. 7.18.1 WINSUN BIO Company Information
  105. 7.18.2 WINSUN BIO Business Overview
  106. 7.18.3 WINSUN BIO Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 WINSUN BIO Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
  108. 7.18.5 WINSUN BIO Recent Developments
  109. 7.19 PULIKE BIOLOGICAL ENGINERING,INC.
  110. 7.19.1 PULIKE BIOLOGICAL ENGINERING,INC. Company Information
  111. 7.19.2 PULIKE BIOLOGICAL ENGINERING,INC. Business Overview
  112. 7.19.3 PULIKE BIOLOGICAL ENGINERING,INC. Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  113. 7.19.4 PULIKE BIOLOGICAL ENGINERING,INC. Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
  114. 7.19.5 PULIKE BIOLOGICAL ENGINERING,INC. Recent Developments
8 North America
  1. 8.1 North America Swine Reproductive and Respiratory Syndrome Vaccine Market Size by Type
  2. 8.1.1 North America Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Type (2021-2032)
  3. 8.1.2 North America Swine Reproductive and Respiratory Syndrome Vaccine Sales by Type (2021-2032)
  4. 8.1.3 North America Swine Reproductive and Respiratory Syndrome Vaccine Price by Type (2021-2032)
  5. 8.2 North America Swine Reproductive and Respiratory Syndrome Vaccine Market Size by Application
  6. 8.2.1 North America Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Application (2021-2032)
  7. 8.2.2 North America Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application (2021-2032)
  8. 8.2.3 North America Swine Reproductive and Respiratory Syndrome Vaccine Price by Application (2021-2032)
  9. 8.3 North America Swine Reproductive and Respiratory Syndrome Vaccine Market Size by Country
  10. 8.3.1 North America Swine Reproductive and Respiratory Syndrome Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Swine Reproductive and Respiratory Syndrome Vaccine Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Swine Reproductive and Respiratory Syndrome Vaccine Market Size by Type
  2. 9.1.1 Europe Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Type (2021-2032)
  3. 9.1.2 Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales by Type (2021-2032)
  4. 9.1.3 Europe Swine Reproductive and Respiratory Syndrome Vaccine Price by Type (2021-2032)
  5. 9.2 Europe Swine Reproductive and Respiratory Syndrome Vaccine Market Size by Application
  6. 9.2.1 Europe Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Application (2021-2032)
  7. 9.2.2 Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application (2021-2032)
  8. 9.2.3 Europe Swine Reproductive and Respiratory Syndrome Vaccine Price by Application (2021-2032)
  9. 9.3 Europe Swine Reproductive and Respiratory Syndrome Vaccine Market Size by Country
  10. 9.3.1 Europe Swine Reproductive and Respiratory Syndrome Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Swine Reproductive and Respiratory Syndrome Vaccine Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Swine Reproductive and Respiratory Syndrome Vaccine Market Size by Type
  2. 10.1.1 China Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Type (2021-2032)
  3. 10.1.2 China Swine Reproductive and Respiratory Syndrome Vaccine Sales by Type (2021-2032)
  4. 10.1.3 China Swine Reproductive and Respiratory Syndrome Vaccine Price by Type (2021-2032)
  5. 10.2 China Swine Reproductive and Respiratory Syndrome Vaccine Market Size by Application
  6. 10.2.1 China Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Application (2021-2032)
  7. 10.2.2 China Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application (2021-2032)
  8. 10.2.3 China Swine Reproductive and Respiratory Syndrome Vaccine Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Swine Reproductive and Respiratory Syndrome Vaccine Market Size by Type
  2. 11.1.1 Asia Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Type (2021-2032)
  3. 11.1.2 Asia Swine Reproductive and Respiratory Syndrome Vaccine Sales by Type (2021-2032)
  4. 11.1.3 Asia Swine Reproductive and Respiratory Syndrome Vaccine Price by Type (2021-2032)
  5. 11.2 Asia Swine Reproductive and Respiratory Syndrome Vaccine Market Size by Application
  6. 11.2.1 Asia Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Application (2021-2032)
  7. 11.2.2 Asia Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application (2021-2032)
  8. 11.2.3 Asia Swine Reproductive and Respiratory Syndrome Vaccine Price by Application (2021-2032)
  9. 11.3 Asia Swine Reproductive and Respiratory Syndrome Vaccine Market Size by Country
  10. 11.3.1 Asia Swine Reproductive and Respiratory Syndrome Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Swine Reproductive and Respiratory Syndrome Vaccine Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Swine Reproductive and Respiratory Syndrome Vaccine Market Size by Type
  2. 12.1.1 SAMEA Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Swine Reproductive and Respiratory Syndrome Vaccine Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Swine Reproductive and Respiratory Syndrome Vaccine Price by Type (2021-2032)
  5. 12.2 SAMEA Swine Reproductive and Respiratory Syndrome Vaccine Market Size by Application
  6. 12.2.1 SAMEA Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Swine Reproductive and Respiratory Syndrome Vaccine Price by Application (2021-2032)
  9. 12.3 SAMEA Swine Reproductive and Respiratory Syndrome Vaccine Market Size by Country
  10. 12.3.1 SAMEA Swine Reproductive and Respiratory Syndrome Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Swine Reproductive and Respiratory Syndrome Vaccine Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Swine Reproductive and Respiratory Syndrome Vaccine Value Chain Analysis
  2. 13.1.1 Swine Reproductive and Respiratory Syndrome Vaccine Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Swine Reproductive and Respiratory Syndrome Vaccine Production Mode & Process
  6. 13.2 Swine Reproductive and Respiratory Syndrome Vaccine Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Swine Reproductive and Respiratory Syndrome Vaccine Distributors
  9. 13.2.3 Swine Reproductive and Respiratory Syndrome Vaccine Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst